Novartis 4Q 4Q Revenues: $12.9 billion (+8%) 4Q Earnings: $2.3 billion (+54%) FY Revenues: $44.3 billion (+7%) FY Earnings: $8.5 billion (+4%) Comments: In the quarter, Pharmaceutical sales were up 21% to $7.8 billion. Vaccines and Diagnostics revenue was up 182% to $1.4 billion and included $1.0 billion of H1N1 pandemic vaccine and adjuvant sales. Sandoz (generic) revenue was up 19% to $2.1 billion. Consumer Health revenues were up 20% to $1.6 billion. For the year, Pharmaceutica...